A Randomized Trial Examining the Effectiveness of Mobile-Based Asthma Action Plans vs. Paper Asthma Action Plans
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Asthma
- Sponsor
- Arkansas Children's Hospital Research Institute
- Enrollment
- 34
- Locations
- 1
- Primary Endpoint
- Change in Asthma Control Test Scores
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
The purpose of this study is to see if using a mobile phone application asthma action plan will help improve asthma management.
Detailed Description
The investigators propose to conduct a randomized trial to examine the effectiveness of a mobile-based Asthma Action Plan that will meet the national guidelines recommendation for individualized Asthma Action Plan treatment plans. The mobile app will provide immediate instructions and feedback once data is entered by the participants. This is an randomized trial which will be compared with an paper asthma action plan. Participants will be randomized through a statistical table. The mobile app will be password and Health Information Portability and Protection Act protected.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age ≥ 12 and ≤ 17 years.
- •Access to Apple or Android based smart phone
- •Mild to severe persistent asthma or poorly controlled asthma (see definitions below).
- •o A different assessment of eligibility will be performed depending on whether or not the parent reports use of a preventive asthma medication at baseline. This is consistent with 2007 National Asthma Education Prevention Program recommendations that make a strong distinction between classifying asthma severity (for children not using preventive medications) and assessing control (for children using preventive medications). If a child has used a preventive medication in the past, but reports no use of the medication in the prior 3 months, we will assess severity.)
- •Children not using a preventive medication at baseline: Assess for mild persistent to severe persistent asthma. Any 1 of the following, during the prior 4 weeks (as defined by parent interview in the waiting room) will determine severity:
- •An average of \>2 days per week with asthma symptoms
- •\>2 days per week with rescue medication use
- •≥2 nights per month awakened with nighttime symptoms
- •Minor limitation of activity
- •≥2 episodes of asthma during the past year that have required systemic corticosteroids
Exclusion Criteria
- •Significant underlying respiratory disease other than asthma (such as cystic fibrosis or chronic lung disease) that could potentially interfere with asthma-related outcome measures.
- •Significant co-morbid conditions (such as moderate to severe developmental delay, i.e. special education classroom or diagnosis) that could preclude participation in an education-based intervention.
- •Inability to speak or understand English (child or parent).
- •Children in foster care or other situations in which consent cannot be obtained from a guardian.
- •Prior enrollment in the study.
Outcomes
Primary Outcomes
Change in Asthma Control Test Scores
Time Frame: Baseline and Six months
The Asthma Control Test™ (ACT) is a 5 question health survey used to measure asthma control in individuals 12 years of age and older. The total sum scores range from 5-25. Higher scores mean that asthma is more controlled. The ACT is an efficient, reliable, and valid method of measuring asthma control, with or without, lung functioning measures such as spirometry. ACT helps identify and detect asthma patients who are not well controlled. ACT scores were examined pre- and post-intervention. A score total of 19 or less means asthma may not be well controlled. The timeframe is during the past 4 weeks. The scale range for Question 1 is "all the time" (1) to "none of the time" (5); Question 2 range: "more than once a day" (1) to "not at all" (5); Question 3 range: "4 or more nights a week" (1) to "not at all" (5); Question 4 range: "3 or more times per day" (1) to "not at all" (5); Question 5 range: "not controlled at all" (1) to "completely controlled" (5).
Secondary Outcomes
- Change in Asthma Self-Efficacy Scores(Baseline and Six months)